Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new stake in Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 5,607 shares of the semiconductor company’s stock, valued at approximately $450,000.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Salomon & Ludwin LLC purchased a new position in shares of Axcelis Technologies in the third quarter valued at approximately $25,000. Close Asset Management Ltd purchased a new stake in Axcelis Technologies during the 3rd quarter worth approximately $27,000. EverSource Wealth Advisors LLC increased its stake in Axcelis Technologies by 145.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 451 shares of the semiconductor company’s stock worth $31,000 after buying an additional 267 shares during the period. Caitlin John LLC acquired a new stake in Axcelis Technologies during the 3rd quarter worth approximately $32,000. Finally, Advisory Services Network LLC purchased a new position in Axcelis Technologies in the 3rd quarter valued at approximately $32,000. 89.98% of the stock is currently owned by hedge funds and other institutional investors.
Axcelis Technologies Stock Performance
Shares of NASDAQ:ACLS opened at $95.09 on Monday. Axcelis Technologies, Inc. has a 52 week low of $40.40 and a 52 week high of $102.93. The company’s 50 day moving average is $87.88 and its two-hundred day moving average is $87.01. The company has a current ratio of 4.77, a quick ratio of 3.11 and a debt-to-equity ratio of 0.04. The company has a market cap of $2.92 billion, a PE ratio of 25.09, a P/E/G ratio of 11.37 and a beta of 1.65.
Analyst Ratings Changes
ACLS has been the subject of several research reports. Bank of America boosted their price target on shares of Axcelis Technologies from $90.00 to $100.00 and gave the stock an “underperform” rating in a research note on Tuesday, January 13th. B. Riley Financial decreased their target price on Axcelis Technologies from $94.00 to $91.00 and set a “neutral” rating for the company in a report on Wednesday, February 18th. Weiss Ratings reissued a “hold (c-)” rating on shares of Axcelis Technologies in a research note on Monday, December 22nd. Zacks Research downgraded Axcelis Technologies from a “hold” rating to a “strong sell” rating in a report on Friday, February 20th. Finally, Wall Street Zen lowered Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, January 3rd. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $101.50.
Get Our Latest Report on Axcelis Technologies
Insiders Place Their Bets
In other news, Director Jorge Titinger sold 1,000 shares of the stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $80.00, for a total value of $80,000.00. Following the transaction, the director owned 6,477 shares in the company, valued at approximately $518,160. This represents a 13.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Russell Low sold 1,244 shares of the firm’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $94.06, for a total value of $117,010.64. Following the sale, the chief executive officer directly owned 132,282 shares in the company, valued at $12,442,444.92. This trade represents a 0.93% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.48% of the stock is owned by company insiders.
Axcelis Technologies Company Profile
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
Read More
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report).
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
